According to Nectar Lifesciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4602. At the end of 2025 the company had a P/S ratio of 0.3053.
Year | P/S ratio | Change |
---|---|---|
2025 | 0.3053 | -40.9% |
2024 | 0.5166 | 17.5% |
2023 | 0.4397 | 34.21% |
2022 | 0.3276 | -15.71% |
2021 | 0.3887 | 24.86% |
2020 | 0.3113 | 202.32% |
2019 | 0.1030 |